Sano: Computational Personalized Medicine

Slides:



Advertisements
Similar presentations
Life Science Cluster in Krakow
Advertisements

Health and Consumers Health and Consumers Future challenges for the EU health workforce Katja Neubauer Deputy Head of Unit Healthcare Systems Directorate-General.
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
Stepping up the Pace Together Dynamic Partnerships Across Community, Academic and Policy Sectors Kevin Miles - Manager of Health Programmes.
Strategy 2012 Karolinska Institutet June 2010Strategy 2012.
KIC InnoEnergy SE - CC Poland Plus Business Creation KIC InnoEnergy Highway Krakow, 12 April 2011.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENSHIP.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Jean Monnet Activities in Erasmus+ Programme - Information on Jean Monnet Activities - Next Call for proposals Selection results Call 2015 (EAC/A04/2014)
NHS Confederation Annual Conference 4 June Matching Health with Growth – the UHB Story.
Horizon 2020 Overview Jerome de Barros NCP Health.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
High Potential Leader Program Brevard Public School District Nancy Rehbine Zentis, Ph.D.
Launch Event 13 October 2016 Motorpoint Arena, Cardiff.
Developing and Broadening Specialists in Research & Development
The UK’s agri-tech sector strategy
Growing great schools. What has the most impact?
A capacity building programme for patient representatives
Our five year plan to improve local health and care services
LH Business change team
Alternative delivery models in public services
Disclosure UK Talking about Transparency.
A Vision for the Future.
The Essentia Institute of Rural Health (EIRH) is
Horizon 2020 – R&D Opportunities
H2020, COEs and PRACE.
ROSEMARY BRYANT AO RESEARCH CENTRE
on behalf of the CECM Project Marian Bubak
Translational Research: Case of Istanbul University
FET Plans FET - Proactive 1.
Dutch Universities of Applied Sciences towards diversified income: Saxion UAS case International Conference on Decentralization in Higher Education from.
RPS: one year on…. Dr Catherine Duggan.
What is €5 billion worth? Magda Gunn, IMI Scientific Project Manager.
Erasmus+ ( ): 3 Key Actions
Health Education England Workforce Strategy - Key Points
Funding opportunities
Disclosure UK Talking about Transparency.
International Research Agendas
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
Research Program Strategic Plan
Finland, a Global Testbed for Personalized Cancer Research?
Introduction to TransCelerate
Human Resources and Mobility in the 6th Framework Programme (FP6)
Department of Medicine Michael Farkouh, Vice-Chair Research michael
Strategic Planning 3/31/2016.
Why & how to launch it in Lithuania?
International Summer School on Integrated Care Daniela Gagliardi
Research for all Sharing good practice in research management
An Industry Perspective Nicole Denjoy COCIR Secretary General
SLE Information.
UCD School of Medicine & Medical Science
Knowledge Translation
Presentation for information days Units involved:
Health Education England Workforce Strategy - Key Points
Clinical and Translational Science Awards Program
Challenges and opportunities of SMEs in the context of future of work and digitalization: Session 4 – Examples of good practices 6 /12/2018 Vice President.
The Canterbury Clinical Network
SLE Information.
Worcestershire Joint Services Review
Challenges and opportunities of SMEs in the context of future of work and digitalization: Session 4 – Examples of good practices 6 /12/2018 Vice President.
Bertelsmann Education Strategy
Millennium Development Goals (MDGs)
SLE Information.
Towards the Center of Excellence for Personalized Diagnostics and Medical Therapy Marian Bubak Academic Computer Cyfronet, Laboratory for Informatics.
EUnetHTA Assembly May 2018.
Towards a Centre for New Methods
Implementing Sláintecare
Strategic Management and
Strategic Management and
Presentation transcript:

Sano Centre for Computational Personalised Medicine – International Research Foundation

Sano: Computational Personalized Medicine Why Sano? Solid Foundations in silico HPC Infrastructure Milestones Projects Consortium Successes Joint Projects Clinical Complexity Ageing What is Sano? Research Products Teaching

In Silico Medicine Complexity The Challenge The Solution Ageing  Co-morbidities Specialists’ Capacity Population-specific Imprecise Diagnosis Suboptimal Treatment Fragmented Care Complexity by composition Unlimited Capacity Subject-specific Precise Diagnosis Ranked Treatments Integrated Care

Healthcare in Poland and Sano Sano addresses the challenges identified in the Poland Country Health Profile and has conducted extensive consultation with medical professionals CFP: Poland lags behind many EU averages in healthcare Our digital technologies offer disruptive improvement Sano addresses Polish issues… and boosts EU leadership in in silico technology 50+ Letters of Interest from medical community

Main objectives of Sano Strong advancement of models, algorithms, and technologies involved in personalised medicine, including design of holistic, replicable, generic framework for simulation-based Decision Support Systems creation Development of new computation-based solutions for diagnostics and therapy in daily healthcare Systematic involvement of regional biomed businesses, specialising in technologies and services for personalised medicine, in high-profile research projects and clinical adoption of their outcome Education initiatives to train knowledge workers with the skills in data analytics, simulation, and HPC/Big Data, to respond to the growing demand for skilled workforce in bio-engineering and medical devices

The partnership Core Consortium Tech/Clinical Funding € Public Venture Capital and Alpha Funds Tech/Clinical Funding € Public € Private Modelling research Healthcare Innovation Hardware HPC skill Benchmarks/monitoring The Centre An independent research foundation Computer science research HPC Lab and hardware Comp Medicine skills Human resources In silico expertise Modelling research Clinical Data Medical Labs Data and Trials Science Technology LifeSci/Med research Human resources Human resources Industry Advice Clinical Data Infrastr’ Talents Fund/Exp’t + 5 major hospitals in PL/UK/DE Data

Towards a successful, sustainable Centre Innovation: New in silico solutions for diagnostics and therapy in daily healthcare Collaboration: Modellers + Healthcare Professionals  identify in silico opportunities State-of-the-art: Advancement of algorithms, models and technologies Exploitation: Regional biomed businesses Education: knowledge transfer in health data analytics, modelling, HPC Foster: young Entrepreneurs  technical/commercial/financial skills

Create a Polish ISCT industry Expected impacts Digital Patient: subject-specific models as decision-support systems for personalised medicine Replace invasive diagnostics Replace indirect prognostics Personalise therapies Improve efficacy Reduce secondary care costs Manage multimorbidity Optimise complex pathways Reducing impact of ageing Externalise management New Polish high-tech start-ups Revitalise medical industry Target rare/neglected disease In Silico Clinical Trials: individualised computer simulation for the development or evaluation of new drugs or medical devices Reduce innovation costs MedTech Pharma Reduce, Refine, and Replace Animal Experimentation More ethical research Create a Polish ISCT industry Personal Health Forecasting: subject-specific models for the self-management of health Self-manage chronicity Refine rural telemedicine Personalise prevention Improve access to care Low-cost MedTech industry Consumer ISM market Reduce primary care costs, Improve quality of life Empower participation SHORT-TERM LONG-TERM

The value chain: from research to healthcare practice Sano has an effective mix of healthcare expertise throughout the value chain Research to Clinical Deployment, across 7 major clinical domains Sano Health Science: Research projects SMEs and Start-ups: Innovations MedTech & Pharma: Access to market Healthcare: Access to patients Industrial corporations 9 Research proposals Therapeutic areas Universities SMEs: Digital Health in Poland 11 11 Regional Hospitals including the most prestigious in Poland, STH in UK 7 3 EU-Industry Partnership EFPIA - IMI Health clusters from the EU 3 6 1 Business Development & Regulatory 3 Technology Park 1 Public body (Regional Medical Info System) 1 Venture Capital 1 Industrial Alliance (Avicenna)

Sano: the community Sano has formal structures for continuous engagement with clinical stakeholders Evidence Quantified Healthcare Meetings 65 meetings Letters of Interest 50 Letters Clinical Committee 9/15 recruited 8 Polish (includes 7 Malopolska) Industrial Advisory 11 members secured, target 20 organisations Leveraging wide consultation during the planning stage: People, institutions, projects, conferences Focus on clinical healthcare requirements Advisory committees: Scientific, Clinical, Industrial Securing tactical commitment and collaboration Strategic partnerships with research hospitals: University Hospital in Krakow Co-location of Sano and Medical Simulation Centre Sheffield Teaching Hospital Heart Prosthesis Institute: co-development of robots

Organization of the Centre Comprised of eminent scientist, the International Scientific Committee ensures that the Centre’s operations and research directions are reviewed from a broad spectrum of scientific viewpoints. The operating activities of the Centre are managed by its Management Board under the supervision of its President who is appointed by the Committee. The Foundation Council is the supervising body of the Centre. Its duties include adopting the Code of Ethics and the Principles of Good Science Practices, and supervising compliance therewith, approving annual reports and financial statements and appointing consulting bodies of the Foundation where needed.

Staff structure: research, development, support and administration Staff balance, mix of high value jobs: R&D, programming, complex support, & IT Research 58%* Development 22% Support 10% Administration 10% Scientific Affairs Director Research Team Leaders Visiting Professors Postdocs PhD Students Business Development Scientific Programming Portfolio Manager Marketing/Fundraising Communications Project Management Project/Portfolio Manager IT Experts (software/hardware) Technical Manager Data Manager Secretariat Financial services (accounting, payroll) Human Resources Legal Office Overlapping roles, e.g. Scientific Programming Manager: 25% research 55% development 10% support 10% administration * Includes stipends

Talent acquisition strategy Healthcare Informatics Data Science In silico techniques Modelling and Simulation Computer Science and HPC The Centre Recruitment of Life Science and IT research and management staff Track record (2017): 8 international CSOs/lab leaders recruited International committees and management : excellence in talent acquisition Search Committee: 6 members (UK, DE, PL) Access to quality candidates Centre’s Management : Led by Scientific Affairs Director Marian Bubak Foundation Council 5 reps of Teaming partners (UK, DE, PL) Concludes employment contracts Int. Scientific Committee : Chaired by Marco Viceconti 15 members (UK, IT, DE, NL, US, PL) Selects top candidates The Network Top international candidates for the Directorship, and Laboratory Leaders Access to local and international Candidates for Middle and Junior Researcher positions Key Performance Indicators KPI-1 Research groups KPI-4 R&D personnel KPI-5 New scientists KPI-6 Foreign scientists KPI-7 Publications (5) (55) (33) (15) (60)

PhD Programme University of Sheffield AGH University of Science and Tech. Staff will (co-)supervise PhD students 4-year PhD program in Computer Science, Biomedical Engineering or Biophysics Typical duration 3.5 years Students will be located mostly at the Centre Option for “industrial PhD” programme with a collaborating company Comprehensive training and research exchange programme Option for “External” PhD degree  Collegium Medicum UJ University of Amsterdam Medicine and other health-related fields External PhD students at UvA Computational Science Special training and Research Exchange Programme At least 6 months abroad USFD advanced training, multi-disciplinary, computational medicine 2 trainings, each of at least 30 hours per student PhD programme in numbers Polish medical researchers involved in PhD co-supervision: 15 (from Clinical Advisory Committee) Total number of PhD students: 30 (18 on salary, 12 stipends)

Activity timeline During the formative phase the Centre will establish its principal administrative bodies and seek candidates to fill key staff positions. The formative phase also entails a search for the Centre director and research team leaders Up until the Centre has attained organizational maturity, the T2 Project Board (PB) will be led by NCBR. The Centre will subsequently assume the leadership, for the Project and the PB, and NCBR will leave the consortium, to prevent potential conflicts of interests. Formative phase Centre acquires legal status Hiring commences Formal bodies established (incl. Search Committee) ISC selects Director candidate Centre formally joins the project Research agenda approved Research leaders recruited Departure of NCBR from consortium Initial performance and portfolio review completed Clinical and industrial engagement assessed  annual report of the Centre IRAP project completes; outcomes evaluated Director’s initial term expires Statutory evaluation by Ministry of Science Self-sustainability Maturity M6 M12 M18 M24 M30 M36 M42 M48 M54 M60 M66 M72 Launch

Sano Teaming Phase 2 project management structure

More at sano.science http://dice.cyfronet.pl/projects and The project is funded by: H2020-WIDESPREAD-2016-2017 TEAMING PHASE 2 program (grant 857533), International Research Agendas program of the Foundation for Polish Science, co-funded by the European Union in the scope of the European Regional Development Fund, Polish Ministry of Science and Higher Education.